Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on December 1, 2017. The filing serves as a Regulation FD disclosure regarding a corporate governance event rather than a periodic financial report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document contains no financial statements or performance data.
Material Changes
The primary material event reported is the adjournment of the Company's special meeting of stockholders. The meeting was rescheduled to December 15, 2017, at 8:00 a.m. Pacific Standard Time. The location remains 201 Mission Street, Suite 2375, San Francisco, CA.
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, future outlook, or specific risk factors. It notes that the information provided is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the new date and time for the special meeting of stockholders (December 15, 2017).
- Review the attached press release (Exhibit 99.1) for details on the agenda of the adjourned meeting.
- Confirm the meeting location at 201 Mission Street, San Francisco.